-
2025-521038-27-00
5
Immune system diseases
-
2023-507600-32-00
5
2025-05-22
Pneumococcal Immunization
-
2025-521035-37-00
5
2026-03-02
Immune system diseases
-
2025-522718-22-00
4
2025-12-16
Gastroesophageal Adenocarcinoma
-
2023-508076-11-00
5
2025-04-01
Colon cancer staged T3-4 and/or nodal positive by CT and/or MRI scan w
-
2022-502352-31-00
5
2025-02-10
Colorectal Cancer (CRC)
-
2022-501187-18-00
5
2023-04-24
a. Diffuse large B-cell lymphoma (DLBCL) not otherwise specified (NOS)
-
2024-511219-78-00
5
2023-02-28
epithelial ovarian cancer
-
2024-514548-10-01
3
2021-07-26
Mild to moderate atopic dermatitis
-
2024-518077-34-00
5
2020-09-30
locally advanced rectal cancer
-
2024-519773-19-00
5
2025-07-31
Gastroesophageal Junction Adenocarcinoma
-
2023-510465-10-00
4
2025-03-10
Meningococcal immunization
-
2024-510719-31-00
5
2025-01-24
Moderate to Severe Vasomotor Symptoms (VMS)
-
2024-512980-29-00
4
2023-08-28
T1-T2N0 esophageal adenocarcinoma including gastroesophageal
junction
-
2024-513610-34-00
4
2023-02-13
HER2-positive, localized esophagogastric adenocarcinoma
-
2024-516271-32-00
5
2020-06-03
Adenocarcinoma of the gastroesophageal junction (AEG type I-III)
-
2024-511577-29-01
5
2020-03-13
intermediate and high-risk rectal cancer
-
2024-513289-21-00
5
2020-01-13
Children with a high risk of developing atopic dermatitis
-
2024-510605-28-00
5
2018-11-27
Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer
-
2024-514945-12-00
10
2018-09-03
locally advanced resectable adenocarcinoma of the oesophagogastric
jun
-
2023-509856-32-00
5
2018-07-15
acute lymphoblastic leukemia in children and adolescents
-
2024-515499-12-00
5
2017-10-02
Acute lymphoblastic leukemia
-
2023-508177-85-00
5
2024-03-12
Healthy volunteers (Meningococcal infection)
-
2022-503113-31-01
4
2023-12-19
longitudinal laparotomy